or Try an Advanced Search...

    Technical Analysis for MIRA - MIRA Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    F 0.82 2.28% 0.02
    MIRA closed up 2.28 percent on Friday, May 31, 2024, on 47 percent of normal volume.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical MIRA trend table...
    Date Alert Name Type % Chg
    20 DMA Support Bullish 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Gapped Up Strength 0.00%
    20 DMA Support Bullish 2.28%
    Wide Bands Range Expansion 2.28%
    50 DMA Resistance Bearish -6.91%
    1,2,3 Pullback Bullish Bullish Swing Setup -6.91%
    Volume Surge Other -6.91%
    Outside Day Range Expansion -6.91%
    Older End-of-Day Signals for MIRA ...

       Recent Intraday Alerts

    Alert Time
    Gap Up Closed 2 days ago
    Gap Up Partially Closed 2 days ago
    Down 5% 2 days ago
    Possible Inside Day 2 days ago
    Gapped Up (Partial) 2 days ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    MIRA Chart by TradingView
    Basic chart:

    Profile

    MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. It is developing MIRA1a, a synthetic cannabinoid analog for treating anxiety and chronic pain by targeting the cannabinoid type 1 and type 2 receptors. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Baltimore, Maryland.
    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - General
    Keywords: Cannabis Euphoriants Chronic Pain Entheogens Cannabinoid Antiemetics Ajulemic Acid Appetite Stimulants

    Is MIRA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 21 MIRA Pharmaceuticals in Discussions with Memorial Sloan Kettering to Collaborate on Preclinical Cancer Pain Model Utilizing The Company's Novel Oral Ketamine Analog
    May 20 Dow Falls Over 150 Points; Sohu Posts Q1 Loss
    May 20 Mira Pharmaceuticals Advances Preclinical Trials Towards an IND Submission This Year for Ketamir-2, a Differentiated Oral Ketamine Analog
    Apr 2 MIRA Making Strides Toward Breakthrough Treatment
    Apr 2 Mira Pharmaceuticals Announces Encouraging Preclinical Results Advancing Ketamir-2 Towards Potential Year-End IND Submission
    Mar 21 MIRA Pharmaceuticals Welcomes Dr. Itzchak Angel, former Head of Pharmacology at Synthelabo, as Chief Scientific Advisor
    Feb 6 Is MIRA Pharmaceuticals (NASDAQ:MIRA) In A Good Position To Deliver On Growth Plans?
    Feb 5 MIRA Pharmaceuticals Provides Corporate Update
    Jan 29 IPO Roundup: Amer Sports, FibroBiologics, and more
    Dec 18 MIRA Pharmaceuticals files to sell up to 1.7M shares for holders
    See more MIRA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 7.9799
    52 Week Low 0.6309
    Average Volume 149,659
    200-Day Moving Average 2.19
    50-Day Moving Average 0.90
    20-Day Moving Average 0.79
    10-Day Moving Average 0.86
    Average True Range 0.12
    RSI (14) 48.45
    ADX 29.82
    +DI 22.30
    -DI 14.06
    Chandelier Exit (Long, 3 ATRs) 0.82
    Chandelier Exit (Short, 3 ATRs) 0.99
    Upper Bollinger Bands 0.97
    Lower Bollinger Band 0.61
    Percent B (%b) 0.57
    BandWidth 45.18
    MACD Line -0.01
    MACD Signal Line -0.02
    MACD Histogram 0.0121
    Fundamentals Value
    Market Cap 12.09 Million
    Num Shares 14.8 Million
    EPS -0.51
    Price-to-Earnings (P/E) Ratio -1.60
    Price-to-Sales 0.00
    Price-to-Book 1.93
    Dividend 0.00
    Dividend Yield 0.00%
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.03
    Resistance 3 (R3) 1.03 0.96 0.99
    Resistance 2 (R2) 0.96 0.91 0.96 0.98
    Resistance 1 (R1) 0.89 0.87 0.85 0.89 0.97
    Pivot Point 0.82 0.82 0.80 0.82 0.82
    Support 1 (S1) 0.75 0.77 0.72 0.75 0.67
    Support 2 (S2) 0.68 0.73 0.68 0.66
    Support 3 (S3) 0.61 0.68 0.64
    Support 4 (S4) 0.61